Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. 14 April 2021. Michael Coyle.

Executive Summary

Medicare carrier Novitas raised its reimbursement rates for continuous cardiac monitoring, but iRhythm has concluded that the rates are still too low and is preparing to discontinue serving its Medicare segment. See what iRhythm CEO Michael Coyle said about it here.

“Unless we are able to establish rates for these codes that allow us to sustainably provide the Zio XT service, we will be forced to stop servicing the Medicare fee-for-service segment under these building codes.” – Michael Coyle, CEO, iRhythm

Click here for a free trial of Medtech Insight

Related Content

Topics

UsernamePublicRestriction

Register

MT143781

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel